FLC Capital Advisors’s CVS Health CVS Stock Holding History

FLC Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,172	Closed	-$246K	–	176
2024 Q2	$246K	Hold	4,172	–	–	0.06%	144
2024 Q1	$333K	Sell	4,172 -938	-18%	-$71.7K	0.08%	118
2023 Q4	$403K	Buy	5,110 +159	+3%	+$11.3K	0.11%	106
2023 Q3	$346K	Sell	4,951 -480	-9%	-$34K	0.1%	111
2023 Q2	$375K	Sell	5,431 -4,000	-42%	-$285K	0.11%	107
2023 Q1	$701K	Sell	9,431 -50	-0.5%	-$4.19K	0.21%	72
2022 Q4	$884K	Sell	9,481 -232	-2%	-$22.4K	0.27%	63
2022 Q3	$926K	Sell	9,713 -1,569	-14%	-$155K	0.32%	67
2022 Q2	$1.04M	Sell	11,282 -500	-4%	-$48.8K	0.35%	64
2022 Q1	$1.19M	Sell	11,782 -500	-4%	-$52.5K	0.33%	67
2021 Q4	$1.27M	Sell	12,282 -393	-3%	-$36.3K	0.35%	71
2021 Q3	$1.08M	Hold	12,675	–	–	0.32%	79
2021 Q2	$1.06M	Sell	12,675 -400	-3%	-$32.8K	0.31%	76
2021 Q1	$984K	Buy	13,075 +7,380	+130%	+$538K	0.31%	77
2020 Q4	$389K	Buy	+5,695	New	+$370K	0.13%	107

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

FLC Capital Advisors's CVS Position: Q3 2024 in Review

FLC Capital Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,172 shares — an estimated $246K sold.

FLC Capital Advisors first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $1.27M in Q4 2021. 1,843 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

FLC Capital Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
FLC Capital Advisors sold 4,172 CVS Health shares in Q3 2024, an estimated $246K.
FLC Capital Advisors first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
FLC Capital Advisors's CVS Health position peaked at $1.27M in Q4 2021.
1,843 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on FLC Capital Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.